FDA Releases Guidance on Bulk Antibiotic Drug Substances

Summary

The Food and Drug Administration (FDA) has made available a new guidance document to help pharmaceutical companies understand the requirements for maintaining Drug Master Files (DMFs) for bulk antibiotic drug substances, following the repeal of a statutory provision in the Federal Food, Drug, and Cosmetic Act.